СРАВНИТЕЛЬНАЯ ОЦЕНКА ХИРУРГИЧЕСКИХ И МАЛОИНВАЗИВНЫХ МЕТОДОВ ЛЕЧЕНИЯ ДГПЖ С УЧЕТОМ РОЛИ ИСКУССТВЕННОГО ИНТЕЛЛЕКТА В ВЫБОРЕ ОПТИМАЛЬНОГО ВМЕШАТЕЛЬСТВА

Библиографические ссылки:

Roehrborn C.G. Benign prostatic hyperplasia: an overview. Rev Urol. 2005; 7(Suppl 9): S3-S14. PMID: 16985902.

Coyne K.S., Wein A.J., Tubaro A. et al. The EpiLUTS study. BJU Int. 2009; 103(Suppl 3): 4-11. https://doi.org/10.1111/j.1464-410X.2009.08371.x

McConnell J.D., Roehrborn C.G., Bautista O.M. et al. The long-term effect of doxazosin, finasteride, and combination therapy (MTOPS). N Engl J Med. 2003; 349(25): 2387-2398. https://doi.org/10.1056/NEJMoa030656

Oelke M., Bachmann A., Descazeaud A., Emberton M., Gravas S., Michel M.C. et al. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms (incl. BPO). Eur Urol. 2013; 64(1): 118-140. https://doi.org/10.1016/j.eururo.2013.03.004

Rassweiler J., Teber D., Kuntz R.M., Hofmann R. Complications of TURP–incidence, management and prevention. Eur Urol. 2006; 50(5): 969-980. https://doi.org/10.1016/j.eururo.2005.12.042

Reich O., Gratzke C., Bachmann A. et al. Morbidity, mortality and early outcome of TURP: prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 180(1): 246-249. https://doi.org/10.1016/j.juro.2008.03.058

Mamoulakis C., Ubbink D.T., de la Rosette J.J. Bipolar vs monopolar TURP: systematic review & meta-analysis of randomized trials. Eur Urol. 2009; 56(5): 798-809. https://doi.org/10.1016/j.eururo.2009.06.037

Hollingsworth J.M., Wilt T.J. Lower urinary tract symptoms in men. BMJ. 2014; 349: g4474. https://doi.org/10.1136/bmj.g4474

Kramer G., Mitteregger D., Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007 May; 51(5): 1202-16. https://doi.org/10.1016/j.eururo.2006

Foster H.E., Barry M.J., Dahm P., Gandhi M.C., Kaplan S.A., Kohler T.S., et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol. 2018; 200(3): 612-619. https://doi.org/10.1016/j.juro.2018.05.048

Di Maida F., Cadenar A., Grosso A.A., Lambertini L., Giudici S., Paganelli D., Salamone V., Mari A., Salvi M., Minervini A., Tuccio A.. Predictors of early catheter replacement after HoLEP. Results from a high-volume laser center. Int Braz J Urol. 2023 Sep-Oct; 49(5): 608-618. https://doi.org/10.1590/S1677-5538.IBJU.2023.0165

Vanthoor J., Herrmann T.R.W., De Coninck V. Can preoperative transurethral catherization reduce the risk of urethral stricture after endoscopic treatment of the prostate? World J Urol. 2025 May 26; 43(1): 325. https://doi.org/10.1007/s00345-025-05474-y

Thomas A.W., Cannon A., Bartlett E., Ellis-Jones J., Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005 Nov; 174(5): 1887-91. https://doi.org/10.1097/01.ju.0000176740.76061.24

Kim S.J., Al Hussein Alawamlh O., Chughtai B., Lee R.K. Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate. Curr Urol Rep. 2018 Aug 20; 19(10): 85. https://doi.org/10.1007/s11934-018-0838-4

Huang S.W., Tsai C.Y., Tseng C.S., Shih M.C., Yeh Y.C., Chien K.L., Pu Y.S., Tu Y.K. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019 Nov 14; 367: l5919. https://doi.org/10.1136/bmj.l5919.

Ahyai S.A., Gilling P., Kaplan S.A., Kuntz R.M., Madersbacher S., Montorsi F., Speakman M.J., Stief C.G. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010 Sep; 58(3): 384-97. . https://doi.org/10.1016/j.eururo.2010.06.005.

Capitán C., Blázquez C., Martin M.D., Hernández V., de la Peña E., Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011 Oct; 60(4): 734-9. https://doi.org/10.1016/j.eururo.2011.05.043

Elkoushy M.A., Elshal A.M., Elhilali M.M. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis. J Endourol. 2015 Jul; 29(7): 797-804. https://doi.org/10.1089/end.2015.0060

Pesonen J.S., Cartwright R., Mangera A., Santti H., Griebling T.L., Pryalukhin A.E., Riikonen J., Tähtinen R.M., Agarwal A., Tsui J.F., Vaughan C.P., Markland A.D., Johnson T.M.2nd, Fonsell-Annala R., Khoo C., Tammela T.L., Aoki Y., Auvinen A., Heels-Ansdell D., Guyatt G.H., Tikkinen K.A. Incidence and Remission of Nocturia: A Systematic Review and Meta-analysis. Eur Urol. 2016 Aug; 70(2): 372-81. https://doi.org/10.1016/j.eururo.2016.02.014.

Lerner L.B., McVary K.T., Barry M.J., Bixler B.R., Dahm P., Das A.K., Gandhi M.C., Kaplan S.A., Kohler T.S., Martin L., Parsons J.K., Roehrborn C.G., Stoffel J.T., Welliver C., Wilt T.J. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021 Oct; 206(4): 806-817. https://doi.org/10.1097/JU.0000000000002183.

Kim M., Lee H.E., Oh S.J. Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia. Korean J Urol. 2013; 54(9): 570-579. https://doi.org/10.4111/kju.2013.54.9.570

Elmansy H.M., Kotb A., Elhilali M.M. HoLEP: 10-year durability. J Urol. 2011; 186(5): 1972-1976. https://doi.org/10.1016/j.juro.2011.06.065

Kuntz R.M., Lehrich K., Ahyai S.A. HoLEP vs open prostatectomy (>100 g): 5-year RCT. Eur Urol. 2008; 53(1): 160-166. https://doi.org/10.1016/j.eururo.2007.08.036

Gilling P.J., Wilson L.C., King C.J., Westenberg A.M., Frampton C.M., Fraundorfer M.R. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012 Feb; 109(3): 408-11. https://doi.org/10.1111/j.1464-410X.2011.10359.x

Lee M.S., Assmus M.A., Ganesh M., Han J., Helon J., Mai Q., Mi X., Krambeck A.E. An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy. Urology. 2023 Mar; 173: 180-186. https://doi.org/10.1016/j.urology.2022.12.018

Ditonno F., Bianchi A., Fumanelli F., Brancelli C., Malandra S., Rizzetto R., Balzarro M., Rubilotta E., Autorino R., Bertolo R., Veccia A., Antonelli A. The Learning Curve for Holmium Laser Enucleation of the Prostate: A Single-Center Analysis of Surgical And Functional Outcomes. J Endourol. 2024 Nov; 38(11): 1226-1233. https://doi.org/10.1089/end.2024.0422.

Martinez-Salas A.J., Garcia-Rivera O.U., Reyna-Blanco I., Jimenez-Garcia A.D., Rosas-Hernandez H. Adequate Mentorship Program for Holmium Laser Enucleation of the Prostate (HoLEP) Leads to Satisfactory Short-Term Outcomes in the Early Learning Curve of Young Urologists: First-Year Outcomes of a Newly Established Mentorship Training in Mexico. Cureus. 2023 Jul 12; 15(7): e41756. https://doi.org/10.7759/cureus.41756

Rücker F., Lehrich K., Böhme A., Zacharias M., Ahyai S.A., Hansen J. A call for HoLEP: en-bloc vs. two-lobe vs. three-lobe. World J Urol. 2021 Jul; 39(7): 2337-2345. https://doi.org/10.1007/s00345-021-03598-5.

Humphreys M.R., Miller N.L., Handa S.E. et al. Outcomes independent of size with HoLEP. J Urol. 2008; 180(6): 2431-2435. https://doi.org/10.1016/j.juro.2008.08.019

Zhao X., Jia L., Li W., Xu H., Ning P., Sha N., Zhang L. Safety and efficacy of low-powered holmium laser enucleation of the prostate in comparison with plasma kinetic resection of prostate. Lasers Med Sci. 2024 Dec 28; 40(1): 2. https://doi.org/10.1007/s10103-024-04261-2

Gratzke C., Bachmann A., Descazeaud A., Drake M.J., Madersbacher S., Mamoulakis C. et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2015; 67(6): 1099-1109. https://doi.org/10.1016/j.eururo.2014.12.038

van Rij S., Gilling P. Recent advances in treatment for Benign Prostatic Hyperplasia. F1000Res. 2015 Dec 21; 4: F1000 Faculty Rev-1482. https://doi.org/10.12688/f1000research.7063.1

Chavali J.S.S., Rivera M.E., Lingeman J.E. HoLEP Learning Curve-Resident Perspective: Survey of Senior Residents from High-Volume Tertiary Center. J Endourol. 2024 Sep; 38(9): 977-981. https://doi.org/10.1089/end.2024.0054

Nedbal C., Gauhar V., Herrmann T., Singh A., Talyshinskii A., Al Jaafari F., Somani B.K. Simulation-based training in minimally invasive surgical therapies (MIST): current evidence and future directions for artificial intelligence integration-a systematic review by EAU endourology. World J Urol. 2025 Jul 18; 43(1): 448. https://doi.org/10.1007/s00345-025-05834-8

Reis G., Yilmaz M., Rambach J., Pagani A., Suarez-Ibarrola R., Miernik A., Lesur P., Minaskan N. Mixed reality applications in urology: Requirements and future potential. Ann Med Surg (Lond). 2021 May 13; 66: 102394. https://doi.org/10.1016/j.amsu.2021.102394

Krambeck A.E., Handa S.E., Lingeman J.E. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2013 Jan; 189(1 Suppl): S141-5. https://doi.org/10.1016/j.juro.2012.11.027

Grosso A.A., Di Maida F., Nardoni S., Salvi M., Giudici S., Lambertini L., Cadenar A., Tellini R., Cocci A., Mari A., Minervini A., Tuccio A. Patterns and Predictors of Optimal Surgical and Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introducing the Concept of "Trifecta". World J Mens Health. 2023 Jul; 41(3): 603-611. https://doi.org/10.5534/wjmh.220042

Pisco J.M., Bilhim T., Costa N.V. et al. PAE in 1000 patients. J Vasc Interv Radiol. 2016; 27(5): 711-721. https://doi.org/10.1016/j.jvir.2016.04.001

Jung J.H., McCutcheon K.A., Borofsky M., Young S., Golzarian J., Kim M.H., Narayan V., Dahm P. Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review. BJU Int. 2023 Jan; 131(1): 32-45. https://doi.org/10.1111/bju.15823

Amouyal G., Tournier L., De Margerie-Mellon C., Pachev A., Assouline J., Bouda D., De Bazelaire C., Marques F., Le Strat S., Desgrandchamps F., De Kerviler E. Safety Profile of Ambulatory Prostatic Artery Embolization after a Significant Learning Curve: Update on Adverse Events. J Pers Med. 2022 Jul 31; 12(8): 1261. https://doi.org/10.3390/jpm12081261

Geevarghese R., Harding J., Parsons N., Hutchinson C., Parsons C. The relationship of embolic particle size to patient outcomes in prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-regression. Clin Radiol. 2020 May; 75(5): 366-374. https://doi.org/10.1016/j.crad.2019.12.019.

Müllhaupt G., Hechelhammer L., Graf N., Mordasini L., Schmid H.P., Engeler D.S., Abt D. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial. Eur Urol Focus. 2024 Sep; 10(5): 788-795. https://doi.org/10.1016/j.euf.2024.03.001.

Xu Z., Zhou Z., Mu Y. et al. PAE vs TURP meta-analysis. Front Surg. 2021; 8: 779571. https://doi.org/10.3389/fsurg.2021.779571

Uflacker A., Haskal Z.J., Bilhim T., Patrie J., Huber T., Pisco J.M. Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic Hyperplasia. J Vasc Interv Radiol. 2016 Nov; 27(11): 1686-1697.e8. https://doi.org/10.1016/j.jvir.2016.08.004

Russo G.I., Kurbatov D., Sansalone S., Lepetukhin A., Dubsky S., Sitkin I., Salamone C., Fiorino L., Rozhivanov R., Cimino S., Morgia G. Prostatic Arterial Embolization vs Open Prostatectomy: A 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities. Urology. 2015 Aug; 86(2): 343-8. https://doi.org/10.1016/j.urology.2015.04.037

Insausti I., Martinez A. More Evidence for Repeat PAE and Different Patterns of Vascular Reperfusion of the Prostate. Cardiovasc Intervent Radiol. 2021 Mar; 44(3): 518-519. https://doi.org/10.1007/s00270-020-02730-z

Bilhim T., Tinto H.R., Fernandes L., Martins Pisco J. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012 Dec; 15(4): 276-85. https://doi.org/10.1053/j.tvir.2012.09.006

Carnevale F.C., de Assis A.M., Moreira A.M. Prostatic Artery Embolization: Equipment, Procedure Steps, and Overcoming Technical Challenges. Tech Vasc Interv Radiol. 2020 Sep; 23(3): 100691. https://doi.org/10.1016/j.tvir.2020.100691

Bilhim T., Pisco J., Campos Pinheiro L., Rio Tinto H., Fernandes L., Pereira J.A., Duarte M., Oliveira A.G. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013 Nov; 24(11): 1595-602.e1. https://doi.org/10.1016/j.jvir.2013.06.003

Jung J.H., McCutcheon K.A., Borofsky M., Young S., Golzarian J., Kim M.H., Narayan V., Dahm P. Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review. BJU Int. 2023 Jan; 131(1): 32-45. https://doi.org/10.1111/bju.15823

Maertens H., Vermassen F., Aggarwal R., Doyen B., Desender L., Van Herzeele I., Annemans L. Endovascular Training Using a Simulation Based Curriculum is Less Expensive than Training in the Hybrid Angiosuite. Eur J Vasc Endovasc Surg. 2018 Oct; 56(4): 583-590. https://doi.org/10.1016/j.ejvs.2018.07.011

Christidis D., Clarebrough E., Ly V., Perera M., Woo H., Lawrentschuk N., Bolton D. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy. World J Urol. 2018 Apr; 36(4): 575-584. https://doi.org/10.1007/s00345-018-2220-z

McVary K.T., Gittelman M.C., Goldberg K.A., Patel K., Shore N.D., Levin R.M., Pliskin M., Beahrs J.R., Prall D., Kaminetsky J. et al. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021 Sep; 206(3): 715-724. https://doi.org/10.1097/JU.0000000000001778

Perera M., Roberts M.J., Doi S.A., Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015 Apr; 67(4): 704-13. https://doi.org/10.1016/j.eururo.2014.10.031